Waystar sells cloud software that helps healthcare providers manage payments, claims, and reimbursement from insurers and patients. WAY reports earnings on Mon, Nov 2, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 7 firms (6 buy, 1 hold, 0 sell). In the past 30 days there were 1 dark pool print.
Prices, price targets and earnings estimates for WAY are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plansSign in
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether WAY is in one of them and how their past WAY trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Waystar Holding
Waystar is a software company based in Lehi, Utah. Its software helps healthcare providers handle payment tasks, including insurance eligibility checks, prior authorizations, medical coding, claims submission, patient payments, and appeals of denied claims. Its customers range from physician practices, clinics, and laboratories to large hospitals and health systems. The company uses artificial intelligence to automate many of these billing and reimbursement steps.
